National Institute of Dental & Craniofacial Research; Notice of Closed Meetings, 79932-79933 [2024-22529]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
79932
Federal Register / Vol. 89, No. 190 / Tuesday, October 1, 2024 / Notices
2. CKD–NEW–12: Increase the
proportion of people with chronic
kidney disease and severe albuminuria
who receive glucose-lowering
medications based on the most recent
guidelines. Data source: National Health
and Nutrition Examination Survey
(NHANES).
3. ECBP–NEW–02: Increase the
proportion of medical schools that
include environmental health content in
a required learning experience. Data
source: American Association of
Colleges of Osteopathic Medicine
(AACOM) and Association of American
Medical Colleges (AAMC) (2022 Annual
Osteopathic Medical School
Questionnaire and Liaison Committee
on Medical Education (LCME); Annual
Medical School Questionnaire Part II).
4. ECBP–NEW–03: Increase the
proportion of undergraduate nursing
and graduate nurse practitioner training
programs that include environmental
health content in a required learning
experience. Data source: American
Association of Colleges of Nursing
(AACN) and National Organization of
Nurse Practitioner Faculties (NONPF)
(2022 American Association of Colleges
of Nursing Healthy People 2030
Curriculum Survey; 2022 National
Organization of Nurse Practitioner
Faculties Healthy People 2030
Curriculum Survey).
5. ECBP–NEW–04: Increase the
proportion of physician assistant (PA)
training programs that include
environmental health content in a
required learning experience. Data
source: Physician Assistant Education
Association (PAEA) (2022 Physician
Assistant Education Association
Healthy People 2030 Survey).
6. ECBP–NEW–05: Increase the
proportion of colleges and schools of
pharmacy with Doctor of Pharmacy
(PharmD) degree programs that include
environmental health content in a
required learning experience. Data
source: American Association of
Colleges of Pharmacy (AACP) (2022
American Association of Colleges and
Pharmacy Healthy People 2030 Survey).
7. ECBP–NEW–06: Increase the
proportion of colleges and schools of
dentistry with Doctor of Dental Surgery
(DDS) and/or Doctor of Dental Medicine
(DMD) degree programs that include
environmental health content in a
required learning experience. Data
source: American Dental Education
Association (ADEA) (2022 ADEA
Healthy People 2030 Survey).
8. EH–NEW–12: Reduce deaths related
to heat. This objective is currently a
development objective, EH–D02. Data
source: National Vital Statistics
System—Mortality.
VerDate Sep<11>2014
17:42 Sep 30, 2024
Jkt 265001
9. HOSCD–NEW–13: Increase the
proportion of adults with
communication disorders of voice,
swallowing, speech, or language who
have seen a health care specialist for
evaluation or treatment in the past 12
months. Data source: National Health
Interview Survey (NHIS), CDC/NCHS.
10. IID–NEW–18: Increase the
proportion of pregnant women who
receive 1 dose of the tetanus-diphtheriaacellular pertussis (Tdap) vaccine
during pregnancy. Data source: National
Health Interview Survey (NHIS), CDC/
NCHS.
11. IID–NEW–19: Increase the
proportion of adults who receive the
recommended age-appropriate vaccine.
Data source: National Health Interview
Survey (NHIS), CDC/NCHS.
12. MICH–NEW–21: Reduce the rate of
hypertension in pregnancy (preexisting
and pregnancy-associated hypertension)
among delivery hospitalizations. Data
source: Healthcare Cost and Utilization
Project—National (Nationwide)
Inpatient Sample (HCUP–NIS), Agency
for Healthcare Research and Quality
(AHRQ).
The public also is invited to provide
comment on the current Healthy People
2030 objectives and propose additional
core, developmental, or research
objectives for consideration that address
critical public health issues. Proposed
new objectives must meet all the
objective selection criteria (see below).
The public is also invited to propose
new topics to be considered for
inclusion in Healthy People 2030.
Objective Selection Criteria
Core Objectives
Core objectives must meet the
following five criteria to be included in
Healthy People 2030. Core objectives
should (1) have a reliable, nationally
representative data source with baseline
data no older than 2015; (2) have at least
two additional data points beyond the
baseline during the decade; (3) be of
national importance; (4) have effective,
evidence-based interventions available
to achieve the objective; and (5) have
data to help address disparities and
achieve health equity.
Developmental Objectives
Developmental objectives will have
the following characteristics: (1)
represent high priority issues; (2) do not
have reliable baseline data yet; and (3)
have evidence-based interventions
available.
Research Objectives
Research objectives will have the
following characteristics: (1) represent
key opportunities to make progress in
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
areas with limited prior research, a high
health or economic burden, or
significant disparities between
population groups; (2) may or may not
have reliable baseline data; and (3) do
not have evidence-based interventions
available.
Written comments and evidencebased information should be submitted
by email to HP2030Comment@hhs.gov
by 11:59 p.m. ET on October 31, 2024.
Comments received in response to this
notice will be reviewed and considered
by the Healthy People topic area
workgroups, Federal Interagency
Workgroup on Healthy People 2030, and
other federal subject matter experts.
Paul Reed,
Deputy Assistant Secretary for Health, Office
of Disease Prevention and Health Promotion.
[FR Doc. 2024–22519 Filed 9–30–24; 8:45 am]
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; Small Research Grants (R03)
for New Investigators and Secondary Data
Analysis PARs Review.
Date: November 6–7, 2024.
Time: 9:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Dental &
Craniofacial Research, 31 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Thomas John O’Farrell,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Activities, National Institute of Dental and
Craniofacial Research, 31 Center Drive,
Bethesda, M.D. 20892, (301) 584–4859, email:
tom.ofarrell@nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
E:\FR\FM\01OCN1.SGM
01OCN1
Federal Register / Vol. 89, No. 190 / Tuesday, October 1, 2024 / Notices
Emphasis Panel; Assessment of Climate at
Institutions (ACt) Award (RC2—Clinical Trial
Not Allowed).
Date: November 8, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Dental &
Craniofacial Research, 31 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Christopher Campbell,
Ph.D., M.D., Scientific Review Officer,
Scientific Review Branch, Division of
Extramural Activities, National Institute of
Dental and Craniofacial Research, 31 Center
Drive, Bethesda, M.D. 20892, (301) 827–4603,
email: christopher.campbell@nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; Prospective Observational
or Biomarker Validation Study Cooperative
Agreement.
Date: November 12, 2024.
Time: 3:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Dental &
Craniofacial Research, 31 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Christopher Campbell,
Ph.D., M.D., Scientific Review Officer,
Scientific Review Branch, Division of
Extramural Activities, National Institute of
Dental and Craniofacial Research, 31 Center
Drive, Bethesda, MD 20892, (301) 827–4603,
email: christopher.campbell@nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: September 26, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–22529 Filed 9–30–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Library of Medicine; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Literature Selection
Technical Review Committee, October
24–25, 2024, 8:30 a.m. to 5 p.m., which
was published in the Federal Register
on July 23, 2024, 89 FR 59744.
This meeting will be amended to
change the meeting time from 8:30 a.m.
to 5 p.m. to 10 a.m. to 4 p.m. for both
days. An open session is added from
10–10:30 a.m. on October 25, 2024.
The open session of the meeting will
be virtual. Any interested person may
file written comments with the
committee by forwarding the statement
to the Contact Person listed on this
VerDate Sep<11>2014
18:53 Sep 30, 2024
Jkt 265001
notice no later than 7 days prior to the
meeting. The statement should include
the name, address, telephone number
and, when applicable, the business or
professional affiliation of the interested
person. Individuals who need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify Dianne
Babski, Associate Director, Division of
Library Operations, National Library of
Medicine at babskid@mail.nih.gov. The
open session will be videocast and can
be accessed from the NIH Videocast
website at https://videocast.nih.gov/.
Dated: September 25, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–22436 Filed 9–30–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Heart, Lung,
and Blood Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will be videocast and can be
access from the NIH Videocasting and
Podcase website https://videocast.
nih.gov/ or https://www.nhlbi.nih.gov/
about/advisory-and-peer-reviewcommittees/advisory-council.
Name of Committee: National Heart, Lung,
and Blood Advisory Council.
Date: October 29, 2024.
Open: 8:00 a.m. to 9:00 a.m., 3:00 p.m. to
5:00 p.m.
Agenda: To discuss program policies and
issues.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892.
Meeting Format: In Person.
Virtual Access: The meeting will be
videocast and can be accessed from the NIH
Videocast. https://videocast.nih.gov/or https://
www.nhlbi.nih.gov/about/advisory-and-peerreview-committees/advisory-council. Please
note, the link to the videocast meeting will
be posted within a week of the meeting date.
Contact Person: Charisee Lamar, Ph.D.,
M.P.H., Director, Division of Extramural
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
79933
Research Activities, National Heart, Lung,
and Blood Institute, National Institutes of
Health, 6705 Rockledge Drive, Room 206–Q,
Bethesda, MD 20892–7924, (301) 827–5517,
Email: lamarc@mail.nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on the notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.nhlbi.nih.gov/about/advisory-and-peerreview-committees/advisory-council where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 26, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–22523 Filed 9–30–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
E:\FR\FM\01OCN1.SGM
01OCN1
]]>Agencies
[Federal Register Volume 89, Number 190 (Tuesday, October 1, 2024)]
[Notices]
[Pages 79932-79933]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-22529]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Dental & Craniofacial Research; Notice of
Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Dental and Craniofacial
Research Special Emphasis Panel; Small Research Grants (R03) for New
Investigators and Secondary Data Analysis PARs Review.
Date: November 6-7, 2024.
Time: 9:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Dental & Craniofacial Research, 31
Center Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Thomas John O'Farrell, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, National Institute of Dental and Craniofacial Research,
31 Center Drive, Bethesda, M.D. 20892, (301) 584-4859, email:
[email protected].
Name of Committee: National Institute of Dental and Craniofacial
Research Special
[[Page 79933]]
Emphasis Panel; Assessment of Climate at Institutions (ACt) Award
(RC2--Clinical Trial Not Allowed).
Date: November 8, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Dental & Craniofacial Research, 31
Center Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Christopher Campbell, Ph.D., M.D., Scientific
Review Officer, Scientific Review Branch, Division of Extramural
Activities, National Institute of Dental and Craniofacial Research,
31 Center Drive, Bethesda, M.D. 20892, (301) 827-4603, email:
[email protected].
Name of Committee: National Institute of Dental and Craniofacial
Research Special Emphasis Panel; Prospective Observational or
Biomarker Validation Study Cooperative Agreement.
Date: November 12, 2024.
Time: 3:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Dental & Craniofacial Research, 31
Center Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Christopher Campbell, Ph.D., M.D., Scientific
Review Officer, Scientific Review Branch, Division of Extramural
Activities, National Institute of Dental and Craniofacial Research,
31 Center Drive, Bethesda, MD 20892, (301) 827-4603, email:
[email protected].
(Catalogue of Federal Domestic Assistance Program No. 93.121, Oral
Diseases and Disorders Research, National Institutes of Health, HHS)
Dated: September 26, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-22529 Filed 9-30-24; 8:45 am]
BILLING CODE 4140-01-P
